CELESTE TUNNELL: Open Payments
NPI 1710925466 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 21 payments from 9 companies in 2025. Trend: 2023 $1,108 · 2024 $166 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $83 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Sage Therapeutics, LLC | 3 | $52 |
| Exact Sciences Corporation | 2 | $49 |
| Astellas Pharma US Inc | 2 | $43 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| CooperSurgical, Inc. | 1 | $14 |
Products named: MYFEMBREE, ZURZUVAE, Cologuard Collection Kit, Veozah, APTIMA, Lynkuet, Kyleena, Mirena.
Industry payments across NV — which companies pay providers there.
